Call for Transparency in Pharmaceutical Pricing After Profit Survey
Tukaram Mundhe has called for transparency in the pharmaceutical industry after a survey revealed a shocking 2,800% profit margin on some products. He emphasized the need for accountability in pricing practices, noting that such high margins are unacceptable for consumers, hospitals, and regulators alike. This situation raises critical concerns regarding the affordability of medications and the implications for healthcare providers, ultimately calling for regulatory reforms to ensure fairness and transparency in pharmaceutical pricing.